The cardiovascular effects of epoxyeicosatrienoic acids (EETs) include vasodilation,
antimigratory actions on vascular smooth muscle cells and anti-inflammatory actions. These …

Hypertension is a frequent condition encountered during kidney disease development and a
leading cause in its progression. Hallmark factors contributing to hypertension constitute a …

Abstract Background and Objective: Patients with End-Stage Kidney Disease (ESKD) have a
unique cardiovascular risk. This study aims at predicting, with a certain precision, death and …

Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left
ventricular hypertrophy progression. Background Regression of left ventricular hypertrophy …

Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and
treatment. Cardiovascular morbidity and mortality importantly influence live expectancy of …

In the United States the prevalence of end-stage renal disease (ESRD) reached epidemic
proportions in 2012 with over 600,000 patients being treated. The rates of ESRD among the …

Background Sleep apnea is an important comorbidity in patients with chronic kidney disease
(CKD) and end-stage renal disease (ESRD). Although the increased prevalence of sleep …

Background Patients undergoing maintenance dialysis are at increased risk of stroke. Study
Design We performed a nationwide retrospective cohort study to determine the risks for …

The association between congestive heart failure and chronic... : Current Opinion in Nephrology
and Hypertension The association between congestive heart failure and chronic renal disease …

Patients with chronic kidney disease (CKD) represent an important segment of the
population (7–10%) and, mostly because of the high risk of cardiovascular complications …